Related references
Note: Only part of the references are listed.Detection and measurement of microparticles: An evolving research tool for vascular biology
Anoop K. Enjeti et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
M. E. T. Tesselaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Elevated platelet microparticle levels in nonvalvular atrial fibrillation - Relationship to P-selectin and antithrombotic therapy
Anirban Choudhury et al.
CHEST (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism
JA Chirinos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
More on: measuring circulating cell-derived microparticles
JM Freyssinet et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway
M Janiszewski et al.
CRITICAL CARE MEDICINE (2004)
Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
É Biró et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus
S Nomura et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus
M Diamant et al.
CIRCULATION (2002)
Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients
M Ando et al.
KIDNEY INTERNATIONAL (2002)
Warfarin, aspirin, or both after myocardial infarction.
M Hurlen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
D Erkan et al.
RHEUMATOLOGY (2002)
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial
RF van Es et al.
LANCET (2002)
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction
CM Boulanger et al.
CIRCULATION (2001)
P-selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease
F Zeiger et al.
BLOOD COAGULATION & FIBRINOLYSIS (2000)
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
Z Mallat et al.
CIRCULATION (2000)
Share Paper
